Showing 2,821 to 2,832 of 4,150 results
US Senator Daines Seeks to Ease US-China Trade Tensions
US Senator Steve Daines arrived in Beijing on March 21, 2025, to discuss trade issues, fentanyl trafficking, and job security with Chinese officials, marking the first high-level political engagement since Donald Trump's return to the White House.
US Senator Daines Seeks to Ease US-China Trade Tensions
US Senator Steve Daines arrived in Beijing on March 21, 2025, to discuss trade issues, fentanyl trafficking, and job security with Chinese officials, marking the first high-level political engagement since Donald Trump's return to the White House.
Progress
36% Bias Score
US-China Trade War: Tariffs and Retaliation
The US has imposed 20% tariffs on Chinese imports, lower than Trump's campaign promise; China retaliated with tariffs on $21 billion of US agricultural goods and other non-tariff barriers, impacting US soybean farmers and potentially major US companies. Further escalation is possible.
US-China Trade War: Tariffs and Retaliation
The US has imposed 20% tariffs on Chinese imports, lower than Trump's campaign promise; China retaliated with tariffs on $21 billion of US agricultural goods and other non-tariff barriers, impacting US soybean farmers and potentially major US companies. Further escalation is possible.
Progress
40% Bias Score
US Alcohol Importers Face $70,000 Tariff Bill Amidst Escalating Trade War
Facing potential 200% tariffs on European alcohol, US importers like Fabrizia Spirits face a $70,000 tariff bill on an Italian wine shipment, highlighting the escalating trade war's impact on small businesses and the broader alcohol industry.
US Alcohol Importers Face $70,000 Tariff Bill Amidst Escalating Trade War
Facing potential 200% tariffs on European alcohol, US importers like Fabrizia Spirits face a $70,000 tariff bill on an Italian wine shipment, highlighting the escalating trade war's impact on small businesses and the broader alcohol industry.
Progress
48% Bias Score
EU Steel Trade Surplus, but Import Restrictions Planned
The European Union recorded a €4.7 billion surplus in iron, steel, and related products trade in 2024, exporting €77.8 billion and importing €73.1 billion, despite a decrease in physical volumes; the EU plans to reduce steel imports by 15% in April 2025 to protect domestic producers.
EU Steel Trade Surplus, but Import Restrictions Planned
The European Union recorded a €4.7 billion surplus in iron, steel, and related products trade in 2024, exporting €77.8 billion and importing €73.1 billion, despite a decrease in physical volumes; the EU plans to reduce steel imports by 15% in April 2025 to protect domestic producers.
Progress
36% Bias Score
US Pharmaceutical Companies Protest Australia's Affordable Medicine Scheme
Australia's Pharmaceutical Benefits Scheme (PBS) subsidizes medicine costs, with the government negotiating lower prices, resulting in a maximum cost of $31.60 per script (decreasing to $25 next year) for Australians. The system is under threat from US pharmaceutical companies, who argue it limits t...
US Pharmaceutical Companies Protest Australia's Affordable Medicine Scheme
Australia's Pharmaceutical Benefits Scheme (PBS) subsidizes medicine costs, with the government negotiating lower prices, resulting in a maximum cost of $31.60 per script (decreasing to $25 next year) for Australians. The system is under threat from US pharmaceutical companies, who argue it limits t...
Progress
52% Bias Score
Trump Urges Rate Cuts Ahead of Tariffs, Fed Holds Steady
President Trump urged the Federal Reserve to cut interest rates before his April 2nd implementation of retaliatory tariffs on Canada and Mexico, aiming to offset potential inflationary pressures, while the Federal Reserve maintained its benchmark rate, citing ongoing inflation concerns and uncertain...
Trump Urges Rate Cuts Ahead of Tariffs, Fed Holds Steady
President Trump urged the Federal Reserve to cut interest rates before his April 2nd implementation of retaliatory tariffs on Canada and Mexico, aiming to offset potential inflationary pressures, while the Federal Reserve maintained its benchmark rate, citing ongoing inflation concerns and uncertain...
Progress
48% Bias Score
US Tech Industry Demands Retaliatory Tariffs Against Australia
US tech giants, winemakers, and drug companies are urging President Trump to impose tariffs on Australian goods in retaliation for what they see as unfair trade practices, including Australia's digital services taxes and local content mandates for streaming platforms, potentially escalating the ongo...
US Tech Industry Demands Retaliatory Tariffs Against Australia
US tech giants, winemakers, and drug companies are urging President Trump to impose tariffs on Australian goods in retaliation for what they see as unfair trade practices, including Australia's digital services taxes and local content mandates for streaming platforms, potentially escalating the ongo...
Progress
52% Bias Score
Visa Stock Faces Recession Risk Amidst High Valuation and Antitrust Concerns
Visa stock (V) faces substantial risk from economic uncertainty, including a potential US recession driven by tariffs and geopolitical tensions, despite its resilience during past downturns; its high valuation and antitrust issues add further concerns.
Visa Stock Faces Recession Risk Amidst High Valuation and Antitrust Concerns
Visa stock (V) faces substantial risk from economic uncertainty, including a potential US recession driven by tariffs and geopolitical tensions, despite its resilience during past downturns; its high valuation and antitrust issues add further concerns.
Progress
60% Bias Score
US-EU Trade War Could Cost Ireland €18 Billion
A report co-authored by the Irish government predicts that a US-EU trade war could cost Ireland more than €18 billion, shrink its GDP by 3.7%, and cause significant job losses, particularly in the pharmaceutical sector, due to potential relocation of US multinationals.
US-EU Trade War Could Cost Ireland €18 Billion
A report co-authored by the Irish government predicts that a US-EU trade war could cost Ireland more than €18 billion, shrink its GDP by 3.7%, and cause significant job losses, particularly in the pharmaceutical sector, due to potential relocation of US multinationals.
Progress
48% Bias Score
Shell's Undervalued Dividend Strength Amidst Market Volatility
Shell PLC (SHEL), featured in the Safest Dividend Yields Model Portfolio, exhibits strong financial health with a 4.2% dividend yield, backed by $145.7 billion in FCF from 2020-3Q24, exceeding its dividend payments and showcasing significant undervaluation with a PEBV ratio of 0.5.
Shell's Undervalued Dividend Strength Amidst Market Volatility
Shell PLC (SHEL), featured in the Safest Dividend Yields Model Portfolio, exhibits strong financial health with a 4.2% dividend yield, backed by $145.7 billion in FCF from 2020-3Q24, exceeding its dividend payments and showcasing significant undervaluation with a PEBV ratio of 0.5.
Progress
44% Bias Score
Fed Holds Rates, Slows Tightening Amid Inflation and Growth Concerns
The Federal Reserve held interest rates steady at 4.25%-4.50% but reduced the pace of quantitative tightening, signaling concern over potential economic slowdown despite higher-than-target inflation projections (2.7% PCE for 2025) and increased unemployment (4.4%).
Fed Holds Rates, Slows Tightening Amid Inflation and Growth Concerns
The Federal Reserve held interest rates steady at 4.25%-4.50% but reduced the pace of quantitative tightening, signaling concern over potential economic slowdown despite higher-than-target inflation projections (2.7% PCE for 2025) and increased unemployment (4.4%).
Progress
32% Bias Score
Australia Defends PBS Subsidies Amidst US Tariff Threats
Australia will maintain its Pharmaceutical Benefits Scheme (PBS) subsidies despite threats of US tariffs on pharmaceutical exports, implementing a $25 cap on prescription medicine if re-elected. The US drug companies argue that Australia's PBS is discriminatory, but Australia counters that maintaini...
Australia Defends PBS Subsidies Amidst US Tariff Threats
Australia will maintain its Pharmaceutical Benefits Scheme (PBS) subsidies despite threats of US tariffs on pharmaceutical exports, implementing a $25 cap on prescription medicine if re-elected. The US drug companies argue that Australia's PBS is discriminatory, but Australia counters that maintaini...
Progress
56% Bias Score
Showing 2,821 to 2,832 of 4,150 results